[
  {
    "ts": null,
    "headline": "Gilead Sciences Commits to Veeva Vault CRM",
    "summary": "Veeva Systems (NYSE: VEEV) today announced that Gilead Sciences has committed to Veeva Vault CRM.",
    "url": "https://finnhub.io/api/news?id=0e14cf1ba029c7e8e73b685322e1e59a7193e3fdbcc498d4a09da90c114db641",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757516580,
      "headline": "Gilead Sciences Commits to Veeva Vault CRM",
      "id": 136689332,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Veeva Systems (NYSE: VEEV) today announced that Gilead Sciences has committed to Veeva Vault CRM.",
      "url": "https://finnhub.io/api/news?id=0e14cf1ba029c7e8e73b685322e1e59a7193e3fdbcc498d4a09da90c114db641"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences, Inc. (GILD) Presents At Baird Global Healthcare Conference 2025 Transcript",
    "summary": "Discover Gileadâs innovations in cell therapy, new product launches, and pipeline updates",
    "url": "https://finnhub.io/api/news?id=cee54f06ded4b433f62319273db625bec3526d453f674ed3b2141e409ba2821d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757511535,
      "headline": "Gilead Sciences, Inc. (GILD) Presents At Baird Global Healthcare Conference 2025 Transcript",
      "id": 136685416,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "Discover Gileadâs innovations in cell therapy, new product launches, and pipeline updates",
      "url": "https://finnhub.io/api/news?id=cee54f06ded4b433f62319273db625bec3526d453f674ed3b2141e409ba2821d"
    }
  },
  {
    "ts": null,
    "headline": "Citizens JMP Initiates IDEAYA Biosciences (IDYA) With a Buy Rating",
    "summary": "IDEAYA Biosciences, Inc. (NASDAQ:IDYA) is one of the Best Stocks to Buy for the Next 3 Months According to Hedge Funds. On September 4, Citizens JMP analyst Ivan Tuerkcan initiated coverage of IDEAYA Biosciences, Inc. (NASDAQ:IDYA) with a $41 price target. The firm started coverage of the company after it announced enrolling the first patient […]",
    "url": "https://finnhub.io/api/news?id=f85da69f770f3c451eb3038dc006dd9e6d17b37aea29572606832a486c88104c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757483976,
      "headline": "Citizens JMP Initiates IDEAYA Biosciences (IDYA) With a Buy Rating",
      "id": 136689333,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "IDEAYA Biosciences, Inc. (NASDAQ:IDYA) is one of the Best Stocks to Buy for the Next 3 Months According to Hedge Funds. On September 4, Citizens JMP analyst Ivan Tuerkcan initiated coverage of IDEAYA Biosciences, Inc. (NASDAQ:IDYA) with a $41 price target. The firm started coverage of the company after it announced enrolling the first patient […]",
      "url": "https://finnhub.io/api/news?id=f85da69f770f3c451eb3038dc006dd9e6d17b37aea29572606832a486c88104c"
    }
  }
]